(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

ADENOVÍRUS E SEUS USOS

ArquivadaInvention PatentPCT · EP2018079725

Application data

Number

112020007695

Type

Invention Patent

Filing

10/30/2018

Publication

10/20/2020

PCT

EP2018079725

Progress at the INPI

  1. Filing10/30/18
  2. Publication10/20/20
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: the INPI technical office action was not answered in time (art. 36 of the Brazilian IP Act). The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 02/10/2026. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

JANSSEN VACCINES & PREVENTION B.V.

NL

See this company's full portfolio

Inventors

J. C. (pessoa física)

NL

S. K. (pessoa física)

NL

S. R. (pessoa física)

NL

T. U. (pessoa física)

NL

Technical data

Priority claims

EP

17199354.6 · 10/31/2017

Abstract

No presente documento são conferidas sequências de ácido nucleico adenovirais e vetores adenovirais compreendendo as referidas sequências de ácido nucleico. Os vetores adenovirais conferidos podem ser usados para induzir uma resposta imune protetora em um sujeito.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento - Art. 36 §1° da LPI

#11.2

02/10/2026

RPI 2875

Parecer de pré-exame

#6.23

08/05/2025

RPI 2848

Adição na publicação

#15.35

11/23/2021

RPI 2655

Notificação de entrada na fase nacional - PCT

#1.3

10/20/2020

RPI 2598

Alteração de dados cadastrais

#1.1

10/06/2020

RPI 2596

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.